These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3098691)

  • 1. Lipoprotein changes induced by pantethine in hyperlipoproteinemic patients: adults and children.
    Bertolini S; Donati C; Elicio N; Daga A; Cuzzolaro S; Marcenaro A; Saturnino M; Balestreri R
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):630-7. PubMed ID: 3098691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of long-term treatment with pantethine in patients with dyslipidemia.
    Arsenio L; Bodria P; Magnati G; Strata A; Trovato R
    Clin Ther; 1986; 8(5):537-45. PubMed ID: 3094958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperlipidemia, diabetes and atherosclerosis: efficacy of treatment with pantethine].
    Arsenio L; Caronna S; Lateana M; Magnati G; Strata A; Zammarchi G
    Acta Biomed Ateneo Parmense; 1984; 55(1):25-42. PubMed ID: 6232801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of pantethine on lipid and lipoprotein abnormalities in survivors of cerebral infarction.
    Murai A; Miyahara T; Tanaka T; Sako Y; Nishimura N; Kameyama M
    Artery; 1985; 12(4):234-43. PubMed ID: 3935096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in fatty acid composition of the single platelet phospholipids induced by pantethine treatment.
    Gensini GF; Prisco D; Rogasi PG; Matucci M; Neri Serneri GG
    Int J Clin Pharmacol Res; 1985; 5(5):309-18. PubMed ID: 4066081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the cholesterol-lowering effectiveness of pantethine in women in perimenopausal age].
    Binaghi P; Cellina G; Lo Cicero G; Bruschi F; Porcaro E; Penotti M
    Minerva Med; 1990 Jun; 81(6):475-9. PubMed ID: 2359503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pantethine improves the lipid abnormalities of chronic hemodialysis patients: results of a multicenter clinical trial.
    Donati C; Barbi G; Cairo G; Prati GF; Degli Esposti E
    Clin Nephrol; 1986 Feb; 25(2):70-4. PubMed ID: 3516477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of bezafibrate on lipoprotein lipids and apolipoproteins B and A1 in patients with primary hypercholesterolemia].
    Branchi A; Sommariva D; Tirrito M; Bonfiglioli D; Pini C; Scandiani L; Orlandi S; Fasoli A
    Clin Ter; 1987 Jul; 122(1):17-23. PubMed ID: 2973892
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical use of pantethine by parenteral route in the treatment of hyperlipidemia].
    Arsenio L; Bodria P; Bossi S; Lateana M; Strata A
    Acta Biomed Ateneo Parmense; 1987; 58(5-6):143-52. PubMed ID: 2970754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pantethine on lipoprotein profiles and HDL subfractions in experimentally hypercholesterolemic rabbits.
    Tomikawa M; Nakayasu T; Tawara K; Kameda KY; Abiko Y
    Atherosclerosis; 1982 Feb; 41(2-3):267-77. PubMed ID: 7066075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pantethine versus fenofibrate in the treatment of type II hyperlipoproteinemia.
    Postiglione A; Rubba P; Cicerano U; Chierchia I; Mancini M
    Monogr Atheroscler; 1985; 13():145-8. PubMed ID: 3911056
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in plasma lipids, lipoproteins and apolipoproteins in hypercholesterolaemic patients treated with pravastatin.
    Lijnen P; Celis H; Desager JP; Fagard R
    J Hum Hypertens; 1995 Jul; 9(7):557-64. PubMed ID: 7562885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pantethine reduces plasma cholesterol and the severity of arterial lesions in experimental hypercholesterolemic rabbits.
    Carrara P; Matturri L; Galbussera M; Lovati MR; Franceschini G; Sirtori CR
    Atherosclerosis; 1984 Dec; 53(3):255-64. PubMed ID: 6442152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
    Grundy SM; Vega GL; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2009 Aug; 104(4):548-53. PubMed ID: 19660610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lowering effect of pantethine on plasma beta-thromboglobulin and lipids in diabetes mellitus.
    Eto M; Watanabe K; Chonan N; Ishii K
    Artery; 1987; 15(1):1-12. PubMed ID: 2963604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of pantethine in dyslipidemia of chronic uremic patients under dialysis treatment].
    Bergesio F; Ciuti R; Innocenti D; Galli GA; Frizzi V
    G Clin Med; 1985; 66(11-12):433-40. PubMed ID: 3835087
    [No Abstract]   [Full Text] [Related]  

  • 18. [Beclobrate (Turec) in the treatment of primary hyperlipoproteinemia. II. Results of the treatment in relation to the type of hyperlipoproteinemia].
    Sznajd J; Idzior-Waluś B; Korzus G; Zabiński J; Hebda A; Markiewicz M
    Przegl Lek; 1990; 47(10):711-4. PubMed ID: 2089450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pantethine, diabetes mellitus and atherosclerosis. Clinical study of 1045 patients].
    Donati C; Bertieri RS; Barbi G
    Clin Ter; 1989 Mar; 128(6):411-22. PubMed ID: 2524328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A double-blind clinical trial--the effects of pantethine on serum lipids in patients with hyperlipidemia].
    Lu ZL
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Aug; 17(4):221-3. PubMed ID: 2697544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.